SightfileU.S. market data from official filings

INCYTE CORP (INCY)

Name: INCYTE CORP (INCY) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000879169 · EDGAR filings · Updated 2026-07-28

INCYTE CORP (INCY) has reported institutional ownership of 99.6%, with 806 institutional managers holding positions valued at $19.0B per the latest 13F reporting period.

Institutional ownership

99.6%

Institutional managers

806

Reported 13F value

$19.0B

Insider activity

155 trans.

−$40.1M net selling

Filings this week (4)

2026-07-28 — Quarterly report (10-Q) filed
2026-07-28 — Current report (8-K) filed
2026-07-27 — Insider transaction reported (Form 4)
2026-07-27 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-20 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)
2026-07-20 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INCYTE CORP has 806 institutional holders and institutional ownership of 99.6%.

#	Institution	Reported value	% of tracked total
1	BAKER BROS. ADVISORS LP	$2.89B	15.2%
2	BlackRock, Inc.	$1.79B	9.4%
3	Dodge & Cox	$1.15B	6.1%
4	VANGUARD CAPITAL MANAGEMENT LLC	$1.03B	5.4%
5	STATE STREET CORP	$907.4M	4.8%
6	VANGUARD PORTFOLIO MANAGEMENT LLC	$730.3M	3.8%
7	AQR CAPITAL MANAGEMENT LLC	$536.1M	2.8%
8	GEODE CAPITAL MANAGEMENT, LLC	$441.1M	2.3%
9	LSV ASSET MANAGEMENT	$369.0M	1.9%
10	Invesco Ltd.	$364.3M	1.9%

Full holder history and quarter-over-quarter changes are available inside the app.

Insider activity

Insiders reported 155 transactions (0 buys, 42 sells) across 28 reporting insiders, with a net reported value of −$40.1M.

Quarterly net insider value, as reported in Form 4 filings.

Related companies

QUEST DIAGNOSTICS INC (DGX) · ILLUMINA INC (ILMN) · REVOLUTION MEDICINES INC (RVMD) · ZIMMER BIOMET HLDGS INC (ZBH) · ALCON AG (ALC) · ROYALTY PHARMA PLC CLASS A (RPRX)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.